142 results
Page 4 of 8
8-K
EX-10.2
v48axawbddbq 32smt
14 Apr 14
NW Bio Announces Financing of Up to $32 Million
12:00am
8-K
EX-10.1
2xt2wefy918
14 Apr 14
NW Bio Announces Financing of Up to $32 Million
12:00am
424B5
ia5qs488
11 Apr 14
Prospectus supplement for primary offering
12:00am
8-K
4op f39ta4pspv33n
13 Mar 14
NW Bio Receives Recommendation To Continue With Phase III GBM Brain Cancer Trial Based On Data Safety Monitoring Board’s Safety Review
12:00am
8-K
EX-99.2
hdzf3ufhs6 9o0e3ws
13 Mar 14
NW Bio Receives Recommendation To Continue With Phase III GBM Brain Cancer Trial Based On Data Safety Monitoring Board’s Safety Review
12:00am
424B5
zh2yroz
21 Nov 13
Prospectus supplement for primary offering
12:00am
424B5
cauctpi
19 Nov 13
Prospectus supplement for primary offering
12:00am
424B5
ll0a8okt3c5e
9 Aug 13
Prospectus supplement for primary offering
12:00am
424B5
p5t52fr7xrb8gi1t4qj
22 Apr 13
Prospectus supplement for primary offering
12:00am
8-K
EX-10.2
v6g9dqil bkcbo
22 Apr 13
NW Bio Announces $10 Million Registered Direct Offering
12:00am
8-K
EX-10.1
3nytwmo4sc1nnq4e
22 Apr 13
NW Bio Announces $10 Million Registered Direct Offering
12:00am
8-K
EX-99.1
2ra7zps
8 Apr 13
NW Bio 2012 ANNUAL REPORT SHOWS STRONG PROGRESS
12:00am
S-3/A
EX-4.5
9i6ixeb8gvwr5unl bgc
25 Jan 13
Shelf registration (amended)
12:00am
S-3/A
EX-4.4
6d2zf
25 Jan 13
Shelf registration (amended)
12:00am
S-3/A
ro0wq 5hc9l2gkkm52
25 Jan 13
Shelf registration (amended)
12:00am
S-3
nudrurty
7 Jan 13
Shelf registration
12:00am